SCHEMBL24252916

SCHEMBL24252916

COc1ccc(CNc2cnnc3cc(-c4cc(Cl)ccc4N4CCOCC4)ccc23)c(OC)c1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE10A Q9Y233 1/20 0.42
KCNH2 Q12809 1/20 0.41
TNIK Q9UKE5 1/20 0.41
GPX4 P36969 1/20 0.38
ALDH1A1 P00352 4/20 0.38
KDM4E B2RXH2 3/20 0.38
CYP1A2 P05177 3/20 0.38
CYP3A4 P08684 3/20 0.38
CYP2C9 P11712 3/20 0.38
TSHR P16473 3/20 0.38
CYP2C19 P33261 3/20 0.38
MAPK1 P28482 3/20 0.38
CYP2D6 P10635 2/20 0.38
TDP1 Q9NUW8 1/20 0.38
CNR1 P21554 1/20 0.38
CNR2 P34972 1/20 0.38
PDE4B Q07343 1/20 0.38
MAPT P10636 3/20 0.38
HSD17B10 Q99714 3/20 0.37
LMNA P02545 2/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30451219 1.00 PDE10A (0.42) PDE10AKCNH2TNIKGPX4ALDH1A1
SCHEMBL24252480 0.94 CNR1 (0.40) ALDH1A1KDM4ECYP1A2CYP3A4CYP2C9
SCHEMBL30462867 0.86 CNR1 (0.40) ALDH1A1KDM4ECYP1A2CYP3A4CYP2C9
SCHEMBL25257307 0.86 CNR1 (0.40) ALDH1A1KDM4ECYP1A2CYP3A4CYP2C9
SCHEMBL30451317 0.85 CYP1A2 (0.46) ALDH1A1KDM4ECYP1A2CYP3A4CYP2C9
SCHEMBL24252808 0.85 CYP1A2 (0.46) ALDH1A1KDM4ECYP1A2CYP3A4CYP2C9
SCHEMBL30462789 0.84 CNR1 (0.39) ALDH1A1KDM4ECYP1A2CYP3A4CYP2C9
SCHEMBL25258545 0.84 CYP1A2 (0.40) ALDH1A1KDM4ECYP1A2CYP3A4CYP2C9
SCHEMBL25262061 0.84 CNR1 (0.39) ALDH1A1KDM4ECYP1A2CYP3A4CYP2C9
SCHEMBL30462875 0.84 CYP1A2 (0.40) ALDH1A1KDM4ECYP1A2CYP3A4CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240109920-A1 INHIBITORS OF COMPLEMENT FACTORS AND USES THEREOF ANNEXON, INC. 2024-04-04 US disclosed
US-11814404-B2 Inhibitors of complement factors and uses thereof ANNEXON, INC. (US) 2023-11-14 US disclosed
US-11814404-B2 Inhibitors of complement factors and uses thereof ANNEXON, INC. (US) 2023-11-14 US disclosed
CN-116947903-A Inhibitors of complement factors and uses thereof 安尼艾克松股份有限公司 2023-10-27 CN disclosed
CN-116261564-A Inhibitors of complement factors and uses thereof 安尼艾克松股份有限公司 2023-06-13 CN disclosed
EP-4185592-A1 INHIBITORS OF COMPLEMENT FACTORS AND USES THEREOF Annexon, Inc. (US) 2023-05-31 EP disclosed
US-20220048930-A1 INHIBITORS OF COMPLEMENT FACTORS AND USES THEREOF ANNEXON, INC. 2022-02-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240109920-A1 INHIBITORS OF COMPLEMENT FACTORS AND USES THEREOF CFB, CFH, C9 PDE10A 1950/4885KCNH2 4467/4885TNIK 2454/4885
US-20220048930-A1 INHIBITORS OF COMPLEMENT FACTORS AND USES THEREOF CFB, CFH, C9 PDE10A 1950/4885KCNH2 4467/4885TNIK 2454/4885
US-11814404-B2 Inhibitors of complement factors and uses thereof CFB, CFH, C9 PDE10A 1950/4885KCNH2 4467/4885TNIK 2454/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.